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Abstract
Background: There is increasing interest to make primary data from published research publicly available. We aimed to
assess the current status of making research data available in highly-cited journals across the scientific literature.
Methods and Results: We reviewed the first 10 original research papers of 2009 published in the 50 original research
journals with the highest impact factor. For each journal we documented the policies related to public availability and
sharing of data. Of the 50 journals, 44 (88%) had a statement in their instructions to authors related to public availability and
sharing of data. However, there was wide variation in journal requirements, ranging from requiring the sharing of all primary
data related to the research to just including a statement in the published manuscript that data can be available on request.
Of the 500 assessed papers, 149 (30%) were not subject to any data availability policy. Of the remaining 351 papers that
were covered by some data availability policy, 208 papers (59%) did not fully adhere to the data availability instructions of
the journals they were published in, most commonly (73%) by not publicly depositing microarray data. The other 143
papers that adhered to the data availability instructions did so by publicly depositing only the specific data type as required,
making a statement of willingness to share, or actually sharing all the primary data. Overall, only 47 papers (9%) deposited
full primary raw data online. None of the 149 papers not subject to data availability policies made their full primary data
publicly available.
Conclusion: A substantial proportion of original research papers published in high-impact journals are either not subject to
any data availability policies, or do not adhere to the data availability instructions in their respective journals. This empiric
evaluation highlights opportunities for improvement.
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Introduction
The observations of scientists as coded in their primary data
constitute a central commodity in the scientific enterprise [1].
Reproduction of research findings and further exploration of
related hypotheses require access to these primary data, and their
public availability has been a concern for all stakeholders of the
scientific process, including regulatory and funding agencies,
journal editors, individual researchers, and patients [2,3,4,5,6,7].
Recently, efforts have converged to encourage making data,
protocols, and analytical codes available, as part of the growing
movement of reproducible research [8,9,10]. The benefits and
challenges of public data availability and data sharing have long
been hotly discussed in the scientific community [11,12,13].
Recent analyses have empirically highlighted deficiencies in the
practice of making primary data and protocols available in peer-
reviewed publications[14,15,16]. These analyses, however, have
focused on either a particular discipline or area of research or were
limited to a single journal. To date, there has not been an empiric
evaluation of public availability of primary data and related
material and protocols across diverse scientific fields or journals.
We aimed to assess the current status of these practices in the most
highly-cited journals across the scientific literature.
Methods
We examined the 50 journals with the highest impact factor
according to the Journal Citation Reports (Science edition 2007)
issued in the Thompson-Institute for Scientific Information Web
of Knowledge. Journals that exclusively publish review articles
were not included. For each journal, we also reviewed the first 10
original research papers published in 2009.
For each journal we documented the policies related to public
availability and sharing of data, where available, and as stated in the
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This was done by one investigator (AA) and verified by a second
(MA). Each paper was reviewed by going through the text,
supplementary material and the links available on the online
version. We recorded information on country of first and
corresponding authors, funding sources, data links and accession
numbers, and whether the paper was based on data covered by a
journal policy (e.g. paper with microarray data published in a
journal requiring public deposition of microarray data). Data
extraction from the 500 papers was done by a single investigator
(WQ) with cross-checking in the first 50 papers by two investigators
(AA and MA). This information was collected in the months of July
and August of 2010. Online information was considered missing if
links were not available when checking on 2 separate occasions 2
weeks apart. We compared the impact factor of journals where
provision of materials and protocols was a condition of publication
versus journals with non-binding instructions or no instructions at
all using the Kruskall-Wallis analysis of variance test. We compared
the proportion of papers depositing full primary data online by
status of US government funding and by geographic origin of
corresponding author (US versus non-US) using the Chi square test.
Results
Of the 50 highest impact factor journals publishing original
research, 44 (88%) had a statement in their instructions to authors
related to public availability and sharing of data from submitted
manuscripts (Appendix S1). However, there was wide variation in
journal requirements, ranging from requiring the sharing of all
primary data related to the research to just including a statement in
the published manuscript that data can be available on request.
Some specific types of data had very high frequency of requirement
for public deposition. This included public deposition of primary
microarray, nucleic acid and protein sequencing data, and
macromolecular structures which was required in 36/50 (72%),
40/50 (80%), 39/50 (78%), and 29/50 (58%) journals (Figure 1).
Materials and protocols used in published experiments were
required to be made available upon request to qualified researchers
by 33/50 (66%) and 23/50 (46%) journals, respectively.
When instructing authors on data or material sharing, journals
used different phrases to indicate how strict these requirements
were. Less than half (22/50, 44%) ofthejournals explicitly indicated
that making materials and/or protocols of the published findings
(regardless of method and technology employed) available to other
qualified investigators was a condition of publication. In their
instructions to authors regarding data sharing, these journals used
language such as ‘‘with minimal restriction . . . in a timely manner’’
(e.g. Cell family of journals), ‘‘non-compliance … may result in
denial of future rights to publish’’ (e.g. Plant Cell), or ‘‘…a condition
of publication . . . is . . to make materials, data and associated
protocols promptly available . . . without preconditions’’ (e.g. Nature
family of journals). An additional 44% (22/50) of the journals had
either a non-binding statement encouraging authors to make their
data available (e.g. using language like ‘‘it is the responsibility of the
authors’’ or ‘‘authors are encouraged to . . .’’), or required a data-
sharing statement by the authors indicating willingness to share
(Annals of Internal Medicine and British Medical Journal). The remainder
6 journals (12%) had no specific instructions to authors related to
data availability. Journals where provision of materials and
protocols was a condition of publication had higher impact factors
compared to journals with non-binding instructions or no
instructions at all (median [25
th,7 5
th percentiles]: 15.14 [11.09,
19.78] versus 12.68 [9.72, 15.98] versus 9.83 [9.13, 11.05], P=0.04
by Kruskal-Wallis analysis of variance).
Figure 1. Breakdown of journal policies for public deposition of certain data types, sharing of materials and/or protocols, and
whether this is a condition for publication and percentage of papers with fully deposited data.
doi:10.1371/journal.pone.0024357.g001
Availability of Published Research Data
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were not subject to any data availability policy (60 were published
in journals without a specific data sharing statement and 89
additional papers contained data not covered by the specific public
deposition policy in their journals). Of the remaining 351 papers
that were covered by some data availability policy (with or without
data deposition as a condition of publication), 208/351 papers
(59%) did not fully adhere to the data availability instructions of
the journals they were published in, most commonly (73%) by not
publicly depositing microarray data. The other 143 papers (of the
351 covered by some data availability policy) that adhered to the
data availability instructions of the journals did so by publicly
depositing only the specific data type as required, making a
statement of willingness to share, or actually sharing all the
primary data. Overall, only 47/500 papers (9%) did deposit full
primary raw data online; and we were able to verify access in all 47
(sites were accessed in July and August 2010). None of the 149
papers not subject to data availability policies made their full
primary data publicly available.
Among papers covered by some data availability policy
(n=351), the proportion depositing full primary data online was
not different when US government funding (e.g. National
Institutes of Health or National Science Foundation) was listed
(15% versus 12% when US funding was not listed, P=0.42) or the
corresponding author was from a US institution (16% versus 11%
for non-US corresponding authors, P=0.20).
Discussion
The present overview of highly cited journals highlights three
main features of the current status of data availability practices in
this high impact scientific literature. First, there are heterogeneous
instructions to investigators publishing in high impact journals,
with some journals requiring public data availability as a condition
for publication, others encouraging data sharing but having no
binding instructions, and a few journals having no specific
instructions at all. Second, nearly a third of the examined sample
of 500 papers were not subject to any data availability policies,
either because they were published in journals without such
policies or with specific policies that do not cover the primary data
upon which the research was based. Third, even when research is
published in journals with specific instructions regarding data
availability, more than half of publications did not adhere to the
data availability instructions in their respective journals.
Our findings present a snapshot of data availability practices in
recent literature. While the papers we reviewed were from 2009, it
is unlikely that the situation has changed much over the past year,
and we therefore believe that the present findings represent
reasonably well the current state of the literature. Moreover, since
the papers we reviewed were likely submitted 6-12 months prior to
our recording of journal policies, some journals may have adopted
data sharing policies in the interim, hence inflating our estimate of
lack of adherence to data sharing policies. However, it is doubtful
that policies related to data sharing have changed substantially
over such a short period of time. We also focused our analysis on
high impact journals, since the research that they publish has a
pivotal role in the evolution of scientific investigation and it is
essential that this pivotal research is reproducible. It is not likely
that data availability practices are more common and more
efficient in other journals with lower impact factor - the opposite
seems more plausible, if anything. Therefore the present findings
may well overestimate the prevalence of effective data sharing
among investigators publishing across all peer-reviewed journals.
In fact, some types of biomedical studies, in particular traditional
epidemiological/observational investigations, may be underrepre-
sented in our sample as compared with molecular and other
clinical research. Some of these types of underrepresented studies
have no established history of public data repositories and thus
primary data availability may be a more critical deficiency in these
fields. It is also worth noting that the association between higher
impact factor and conditioning publication upon provision of
materials/protocols may be confounded by type of journal, as
experimental/basic science journals that typically have such
conditions tend to have higher impact factors.
While this analysis highlights an important element of data
sharing, that of public availability of primary data, there are other
elements not evaluated here but still important to make the data
sharing culture functional and efficient. For example, a statement
of willingness to share raw data by the primary investigators does
not always translate into true availability of data when requested
by independent scientists [15]. Empirical studies suggest that data
withholding is not uncommon in the scientific community and
may be influenced by industry relationships, perceptions of
proprietary information and scientific priority, lack of resources,
and personal investigator training and stances towards data
sharing[17,18,19]. Moreover, while all data web links of full
primary datasets were verified as functioning in our analysis, this
may reflect the temporal proximity of our analysis to the
publication date of the articles, and some of these links may
become unavailable a few years later [20].
Legislation to make results of clinical trials publicly available
within one year of study completion may promote the culture of
transparency in clinical trials research, but at present such
legislation does not mandate making raw data from clinical trials
publicly available [21]. Indeed, widespread availability of clinical
trial data may be hampered by financial incentives of journals to
publish industry-sponsored trials, many of which may be bound by
confidentiality agreements [22,23,24]. Data sharing may be
enhanced when granting agencies require investigators to share
data but regulatory barriers remain [25,26].
Finally, for data that was made available by investigators, we did
not attempt to replicate their findings. Even when data are
publicly available, published results are often not reproducible by
independent investigators due to incomplete annotation or
specification of data processing and analyses [14].
This empiric evaluation highlights opportunities for improve-
ment. Journals should adopt more routinely policies for data
sharing, expanding the types of data that are subject to public
sharing policies with the ultimate target of covering all types of
data. Moreover, it is essential to develop mechanisms for journals
to ensure that existing data availability policies are consistently
followed by researchers and published research findings are easily
reproducible.
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